Unfortunately I don’t think at these levels it is in shareholder interest to become a T/O target.
Be very cheap for anyone in emergency medicine, especially if they sell of the respiratory business.
I would rather see the Board and Management get this companies MOJO back with a solid plan for Europe, progress to improving the profitability with CSIRO flow process and timeline for the new selfie device that has been spoken of for years.
We can only hope there is a grand plan happening in the background.
Unfortunately I don’t think at these levels it is in shareholder...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $34.95M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 39.5¢ | $22.96K | 57.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26298 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 13002 | 3 |
View Market Depth
| Last trade - 11.10am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
40.0¢ |
Change
-0.005 ( 0.15 %) |
||||
| Open | High | Low | Volume | ||
| 40.0¢ | 40.5¢ | 39.5¢ | 14206 | ||
| Last updated 12.03pm 21/05/2024 ? | |||||
| MVP (ASX) Chart |